A new TNM classification is better than ISS at predicting survival in stage III unresectable non-small cell lung cancer (NSCLC). A study by the European lung cancer working party (ELCWP) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003
Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis Source: Eur Respir J 2007; 30: Suppl. 51, 669s Year: 2007
The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014
Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC) Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015
June 4: Ebus in staging lung cancer Source: Year: 2008
Staging of lung cancer Source: Eur Respir Mon; 2009: 44: 150–168 Year: 2009
Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010
Independent prognostic und predictive value of blood vessel invasion (BVI) in curatively (R0) resected stage II and IIIA non-small cell lung (NSCLC) cancer patients Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
Lung cancer: staging with respect to the new 8th TNM-classification Source: International Congress 2018 – Imaging Grand Round Year: 2018
Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006
A population-based evaluation of the seventh edition of the TNM system for lung cancer Source: Eur Respir J 2010; 36: 401 Year: 2010
Assessment of DNA ploidy and proliferating activity changes in neoplasmatic cells according to TNM classification and clinical stages in non-small cell lung cancer (NSCLC) patients during chemotherapy Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015
Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC) Source: International Congress 2016 – EBUS and transthoracic ultrasound Year: 2016
LATE-BREAKING ABSTRACT: Prognostic value of microRNAs expression in stage I-IIIA lung adenocarcinoma (AC) Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
A proposal in small cell lung cancer staging according to TNM system Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012